ArticleBMC medical informatics and decision making2026
Prediction of malignancy and metastasis of thyroid cancer by combined feature sets through advanced machine learning.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundPredicting thyroid cancer (TC) and its accompanying metastasis remains challenging because of the complexity of the disease and its diverse pathological subtypes. The complexity and variability of TC necessitate innovative approaches that leverage machine learning (ML) and deep learning (DL) for enhanced accuracy in diagnosis and lymph node metastasis (LNM) prediction.
methods803 patients were examined using ultrasound for thyroid nodules, inculing 369 benign nodules, and 433 malignant nodules, of which 118 were LNM. All patients were diagnosed by pathologists based on preoperative and postoperative specimens. Transfer learning was used to extract the features of ultrasound two dimensional images. Using images and matched clinical characteristics, we incorporated two-dimensional imaging features and tabular clinical features to predict both malignancy and LNM. We considered several ML models, including a random forest classifier, gradient boost classifier, XGB classifier, Naïve Bayes, and multilayer perceptron. The area under the receiver operating characteristic curve was used to benchmark model performance.
resultsThe AI model demonstrated notable diagnostic precision, achieving AUROC scores of 0.82 for TC diagnosis and 0.78 for LNM prediction. Crucially, the prediction model demonstrated a synergistic performance when both clinical characteristics and ultrasonographic images were combined, underscoring the complementary strengths of each data type in improving diagnostic accuracy. It should be noted that TI-RADS was significantly correlated with both malignancy and LNM. However, the optimized model was a gradient-boosting model with 12 features and a cross-validation AUROC of 0.82, indicating that imaging features can appreciably summarize the details of the ultrasonographic images for these patients.
conclusionThis study delves into the nuanced integration of imaging and clinical data through the advanced ML, encompassing both traditional ML techniques and DL, to enhance the diagnostic precision and therapeutic strategies for TC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.